DEPOCYT vs OFORTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. DEPOCYT and OFORTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPOCYT	OFORTA
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CYTARABINE	FLUDARABINE PHOSPHATE
Manufacturer	Pacira Pharms Inc	Sanofi Aventis US
Dosage forms	Injectable, Liposomal	Tablet
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Non-Hodgkin Lymphoma, B-Cell Chronic Lymphocytic Leukemia

depocyt oforta

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

CYTARABINE

FLUDARABINE PHOSPHATE

Manufacturer

Pacira Pharms Inc

Sanofi Aventis US

Dosage forms

Injectable, Liposomal

Tablet

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Non-Hodgkin Lymphoma, B-Cell Chronic Lymphocytic Leukemia

Frequently asked questions

Which is better-rated, Depocyt or Oforta?

By our independent rating, Depocyt scores higher — 3.6 vs 3.5 out of 5 for Oforta. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depocyt and Oforta?

Depocyt contains Cytarabine, while Oforta contains Fludarabine Phosphate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.